USD/BRL edged higher near key resistance at 5.40, with traders watching for a breakout toward 5.4685 or a reversal as global market volatility rises.

USD/ZAR surged toward 17.58 before pulling back slightly, with traders eyeing key resistance at 17.4750 as market volatility and Fed uncertainty persist.

The US dollar rebounded against the Swiss franc, hinting at a potential breakout as SNB intervention risks and broader dollar strength drive bullish momentum.

Decreased full-year guidance, margin pressure, and high valuations overshadow a strong immunology growth rate. How did earnings impact AbbVie’s outlook?

A massive earnings beat sent shares rallying, but the latest GLP-1 treatment underperformed, while long-term debt is rising and profit margins are shrinking. Did earnings justify the rally in Eli Lilly?

Concerns over profit margins, excessive valuations, and a dismal return on invested capital overshadowed excellent earnings. Will earnings spark a correction in AMD?